Leal Leticia Ferro, Szarek Eva, Faucz Fabio, Stratakis Constantine A
Section on Endocrinology and Genetics, Program on Developmental Endocrinology & Genetics (PDEGEN) Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institutes of Health, 10 Center Drive, Building 10, NIH-Clinical Research Center, Room 1-3216, Bethesda, MD, 20892, USA.
Endocrine. 2015 Sep;50(1):27-31. doi: 10.1007/s12020-015-0621-y. Epub 2015 May 14.
Bilateral adrenocortical hyperplasia (BAH) in humans and mice has been recently linked to phosphodiesterase (PDE) 8B (PDE8B) and 11 (PDE11A) defects. These findings have followed the discovery that defects of primary genes of the cyclic monophosphatase (cAMP) signaling pathway, such as guanine nucleotide binding alpha subunit and PRKAR1A, are involved in the pathogenesis of BAH in humans; complete absence of Prkar1a in the adrenal cortex of mice also led to pathology that mimicked the human disease. Here, we review the most recent findings in human and mouse studies on PDE8B, a cAMP-specific PDE that appears to be highly expressed in the adrenal cortex and whose deficiency may underlie predisposition to BAH and possibly other human diseases.
人类和小鼠的双侧肾上腺皮质增生(BAH)最近被发现与磷酸二酯酶(PDE)8B(PDE8B)和11(PDE11A)缺陷有关。这些发现是在发现环磷酸单酯酶(cAMP)信号通路的初级基因缺陷,如鸟嘌呤核苷酸结合α亚基和PRKAR1A,参与人类BAH发病机制之后;小鼠肾上腺皮质中Prkar1a的完全缺失也导致了类似于人类疾病的病理变化。在此,我们综述了人类和小鼠关于PDE8B研究的最新发现,PDE8B是一种cAMP特异性磷酸二酯酶,似乎在肾上腺皮质中高度表达,其缺陷可能是BAH易感性以及可能其他人类疾病的潜在原因。